Curis (CRIS) Capital Expenditures (QoQ) (2010 - 2022)
Curis (CRIS) Capital Expenditures (QoQ) (2010 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -85.27% |
| Jun 30, 2022 | 3,109.09% |
| Dec 31, 2020 | -87.34% |
| Sep 30, 2020 | -38.76% |
| Jun 30, 2020 | 7.05% |
| Mar 31, 2018 | 87.80% |
| Dec 31, 2017 | 95.24% |
| Sep 30, 2017 | -71.62% |
| Jun 30, 2017 | 42.31% |
| Mar 31, 2017 | -13.33% |
| Dec 31, 2016 | 361.54% |
| Sep 30, 2016 | -94.76% |
| Jun 30, 2016 | 3,000.00% |
| Sep 30, 2015 | 76,644.19% |
| Jun 30, 2015 | -99.71% |
| Mar 31, 2015 | -42.99% |
| Dec 31, 2014 | 280.07% |
| Dec 31, 2013 | -81.35% |
| Mar 31, 2013 | -44.34% |
| Dec 31, 2012 | 637.71% |